Bio Green Med Solution (BGMS) Profit After Tax (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Profit After Tax of -$197000.0 for Q1 2026, down 143.21% year-over-year from $455914.3 in Q1 2025, and up 62.76% quarter-over-quarter from -$529000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Profit After Tax (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Profit After Tax for 17 consecutive years, with -$197000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 143.21% year-over-year to -$197000.0; the TTM figure through Mar 2026 stood at -$3.1 million (up 63.35% YoY), while the FY2025 annual figure was -$3.2 million, up 71.54% from the prior year.
- Profit After Tax climbed to -$197000.0 in Q1 2026 per BGMS's latest filing, from -$529000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at -$81000.0 in Q1 2025 and bottomed at -$7.6 million in Q4 2022.
- Historically, Profit After Tax has averaged -$3.4 million across 5 years, with a median of -$3.3 million in 2024.
- Annual changes were most pronounced in 2025 — Profit After Tax soared 97.25% — and 2026, when it plunged 143.21%.
- Bio Green Med Solution's Profit After Tax stood at -$7.6 million in 2022, then advanced by 28.19% to -$5.5 million in 2023, then soared by 44.23% to -$3.1 million in 2024, then soared by 82.67% to -$529000.0 in 2025, then soared by 62.76% to -$197000.0 in 2026.
- Business Quant data shows BGMS's Profit After Tax at -$197000.0 in Q1 2026, -$529000.0 in Q4 2025, and -$1.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -16.62 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | -405,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -405,000.00 |
| Mar 31, 2026 | -197,000.00 |
| Dec 31, 2025 | -11.43 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -1.32 Mn |
| Mar 31, 2025 | -81,000.00 |
| Dec 31, 2024 | -5.12 Mn |
| Sep 30, 2024 | -1.96 Mn |
| Jun 30, 2024 | -3.26 Mn |
| Mar 31, 2024 | -2.95 Mn |
| Dec 31, 2023 | -5.32 Mn |
| Sep 30, 2023 | -6.08 Mn |
| Jun 30, 2023 | -5.45 Mn |
| Mar 31, 2023 | -5.80 Mn |
| Dec 31, 2022 | -7.47 Mn |
| Sep 30, 2022 | -5.15 Mn |
| Jun 30, 2022 | -4.58 Mn |
| Mar 31, 2022 | -4.11 Mn |
| Dec 31, 2021 | -5.30 Mn |
| Sep 30, 2021 | -4.76 Mn |